TLPH
Talphera Inc.NASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$39.54M
P/E Ratio
—
EPS
$-0.34
Beta
0.56
52W High
$1.57
52W Low
$0.38
50-Day MA
$0.85
200-Day MA
$0.88
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.02
PEG Ratio
—
About Talphera Inc.
Talphera Inc. is a pioneering biotechnology firm specializing in the development of advanced therapies targeting rare diseases and significant unmet medical needs. The company leverages its expertise in peptide-based therapeutics to address critical challenges in cancer treatment and other high-need health areas. With a robust pipeline of innovative therapeutic candidates and a strong dedication to research excellence, Talphera is well-positioned for transformative contributions to the healthcare sector. For institutional investors, Talphera represents a compelling opportunity to engage with a growth-oriented company in the expanding biotechnology landscape.
Fundamentals
| Revenue (TTM) | 28,000 |
| Gross Profit (TTM) | -218,000 |
| EBITDA | $-15.16M |
| Operating Margin | -48157.00% |
| Return on Equity | -114.70% |
| Return on Assets | -35.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.34 |
| Price-to-Book | 2.09 |
| Price-to-Sales (TTM) | 1412.12 |
| EV/Revenue | 543.02 |
| EV/EBITDA | 0.11 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $50.05M |
| Float | $25.15M |
| % Insiders | 25.43% |
| % Institutions | 40.74% |
Historical Volatility
HV 10-Day
80.54%
HV 20-Day
87.54%
HV 30-Day
77.99%
HV 60-Day
75.69%
HV Rank
46.8%
Volatility is currently expanding
Data last updated: 4/9/2026